Patient Management

2074 questions

All types2,074 Multiple choice1,048 Multiple select393 Matching221 Ordering412

During morning rounds on hospital day 5, a 65-year-old male patient is assessed. He was admitted for community-acquired pneumonia and has a medical history significant for a mechanical mitral valve replacement performed 4 years ago. His home medications include warfarin and metoprolol. Upon admission, empiric treatment was initiated with intravenous ceftriaxone and oral azithromycin. On hospital day 3, this regimen was changed to oral levofloxacin based on sputum culture susceptibilities.

His respiratory symptoms have largely resolved. When interviewed today, the patient denies any hemoptysis, hematuria, melena, or easy bruising. Vital signs are within normal limits. Physical examination demonstrates a crisp mechanical first heart sound and lungs that are clear to auscultation bilaterally. There is no clinical evidence of petechiae or mucosal bleeding.

Morning laboratory studies show:
- Hemoglobin: 13.5 g/dL
- Platelet count: 210,000/mm³
- Serum creatinine: 1.1 mg/dL
- International Normalized Ratio (INR): 7.4 (Admission INR: 2.8)

Which of the following is the most appropriate next step in the management of this patient's anticoagulation?

Withhold warfarin and monitor the International Normalized Ratio daily

Withhold warfarin and administer oral phytonadione

Withhold warfarin and administer prothrombin complex concentrate

Decrease the warfarin dose by 50% and continue daily administration

Continue the current warfarin dose and discontinue levofloxacin

Show answer & explanation

Answer: Withhold warfarin and monitor the International Normalized Ratio daily

Answer

Withhold warfarin and monitor the International Normalized Ratio daily

The patient has a supratherapeutic INR of 7.4 without any evidence of clinically significant bleeding. According to current guidelines for the management of supratherapeutic anticoagulation with warfarin, patients with an INR between 4.5 and 10.0 without bleeding should have warfarin withheld for 1 to 2 doses. The INR should be monitored frequently, and warfarin can be resumed at an appropriately adjusted dose once the INR returns to the therapeutic range. Routine administration of oral vitamin K is no longer recommended for this specific INR range due to the risk of overcorrection and prolonged warfarin resistance. This is particularly hazardous in patients with mechanical heart valves who are at a high baseline risk for valve thrombosis if their INR becomes subtherapeutic.

Step-by-Step Solution

Evaluate the patient's current clinical status and laboratory results.

The patient has a significantly elevated INR of 7.4 but is completely asymptomatic with no signs of active bleeding.

The presence or absence of bleeding dictates whether emergent reversal is needed versus conservative management.

Identify the likely cause of the supratherapeutic INR.

The recent initiation of levofloxacin is the probable culprit.

Fluoroquinolones inhibit warfarin metabolism and alter gut flora, increasing the anticoagulant effect.

Apply guidelines for managing a supratherapeutic INR without bleeding.

For an INR between 4.5 and 10.0 without bleeding, the recommended action is to withhold 1 or 2 doses of warfarin.

Withholding doses allows the INR to drift back to the therapeutic range gradually, avoiding the risk of overcorrection associated with active reversal agents.

Key Concept

For patients on warfarin who develop an INR between 4.5 and 10.0 without clinically significant bleeding, the most appropriate management is to withhold warfarin and monitor the INR, without administering vitamin K.

Question 1562Question →

A primary care physician is evaluating several ambulatory patients who have not been taking their prescribed therapies. To improve clinical outcomes, the physician must tailor their approach to the specific underlying barrier. Select the most appropriate initial counseling strategy or intervention for each of the following patient scenarios.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Each patient statement must be matched to the counseling strategy that directly addresses their specific root cause of non-adherence: adverse effects, health beliefs, financial constraints, and regimen complexity, respectively.

Matching the correct counseling strategy to the specific barrier ensures that the intervention is patient-centered and effective. Validating side effects builds trust; correcting health beliefs addresses knowledge gaps; providing financial resources overcomes systemic barriers; and simplifying regimens reduces cognitive overload.

Step-by-Step Solution

Analyze each patient's statement to determine the underlying barrier to medication adherence.

Identified barriers: adverse medication effect, misunderstanding of disease process, cost/financial constraint, and regimen complexity.

Targeted counseling is only effective when it addresses the specific root cause of the patient's non-adherence.

Select the physician intervention that directly mitigates the identified barrier.

Matched each barrier to its corresponding practical clinical or educational solution.

Applying mismatched strategies will fail to improve patient adherence or clinical outcomes.

Key Concept

Tailoring physician counseling and clinical interventions to the specific barrier causing medication non-adherence.

Question 1563Question →

A 74-year-old man with end-stage chronic obstructive pulmonary disease (COPD) is enrolled in home hospice care. He is currently utilizing his continuous home oxygen therapy and maximum tolerated inhaled bronchodilators. Over the ensuing weeks, he begins to experience distressing, progressive episodes of dyspnea at rest. Arrange the following interventions in the most appropriate stepwise sequence for managing his terminal dyspnea, starting from the most appropriate initial next step to the final intervention of last resort.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with non-pharmacologic measures (fan therapy), followed by first-line pharmacologic therapy (systemic opioids), then adjuvant therapy for specific symptom clusters (benzodiazepines for anxiety), and finally, the intervention of last resort (palliative sedation).

In the management of terminal dyspnea, therapy should be escalated in a stepwise fashion based on risk and efficacy. Non-pharmacologic measures (like a fan) are extremely low-risk and often effective. When pharmacologic intervention is required, systemic opioids (like morphine) are the gold-standard first-line agents, as they centrally relieve the sensation of breathlessness. If the patient develops concurrent severe anxiety or panic that exacerbates the dyspnea, benzodiazepines are added as adjuvants. Finally, if the dyspnea becomes entirely refractory to these measures and causes unendurable suffering in the dying patient, palliative sedation (e.g., continuous midazolam) is utilized as the absolute last resort to ensure comfort.

Step-by-Step Solution

Identify the initial, lowest-risk intervention for terminal dyspnea.

Non-pharmacologic measures such as a fan directed at the face.

Cool air on the face stimulates trigeminal nerve receptors, providing immediate subjective relief with zero risk of adverse pharmacologic effects, making it the ideal first step.

Determine the first-line pharmacologic agent for dyspnea unresponsive to non-pharmacologic measures.

Low-dose, short-acting systemic opioids (e.g., oral morphine).

Opioids are the cornerstone of pharmacologic dyspnea management in terminal illness, effectively reducing ventilatory drive and the perception of breathlessness without significantly compromising gas exchange when dosed carefully.

Identify the role of adjuvant medications.

Addition of a benzodiazepine (e.g., lorazepam).

Benzodiazepines are not indicated for dyspnea itself but are the appropriate next step when dyspnea is compounded by severe anxiety or panic that is refractory to the reassurance provided by opioids.

Determine the final intervention for truly intractable symptoms.

Palliative sedation.

When all other measures fail to relieve suffering in a terminally ill patient, proportionate palliative sedation to unconsciousness is the ethical and clinical last resort.

Key Concept

The stepwise management of terminal dyspnea prioritizes low-risk non-pharmacologic interventions, followed by systemic opioids as the primary pharmacologic treatment, adjuvants like benzodiazepines for concurrent anxiety, and reserves palliative sedation as a final resort for intractable suffering.

Estimated Time:1m 30s

Question 1564Question →

A 24-year-old individual presents to the emergency department with severe chest tightness, expiratory wheezing, and significant accessory muscle use. The patient has a history of moderate persistent asthma but recently exhausted their supply of maintenance inhalers. Oxygen saturation is 88% on ambient air. The clinical team prepares to manage this severe acute exacerbation.

Arrange the following therapeutic and monitoring steps in the most appropriate chronological sequence for managing this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with immediate bronchodilation and oxygen, followed by systemic corticosteroids, then objective reassessment of airflow, escalating to intravenous magnesium for refractory symptoms, and finally initiating mechanical ventilatory support if respiratory fatigue occurs.

The established protocol for severe asthma exacerbations dictates a step-up approach, heavily relying on continuous monitoring and treatment evaluation. Hypoxia and severe bronchospasm are the most immediate threats and must be addressed first with oxygen, albuterol, and ipratropium. Systemic corticosteroids should be administered concurrently or immediately following to begin combatting the severe inflammatory response. The critical 'monitoring and evaluation' step occurs next: assessing the patient's clinical work of breathing and peak expiratory flow (PEF) after initial therapy. If the patient demonstrates a poor response (e.g., PEF remains below 40% of predicted), therapy is escalated to intravenous magnesium sulfate. If the patient subsequently develops hypercapnia or exhaustion despite maximal pharmacological therapy, mechanical support via continuous positive airway pressure (CPAP) or endotracheal intubation is required.

Step-by-Step Solution

Identify the immediate life-threatening issues (hypoxia and severe bronchospasm).

Prioritization of oxygenation and short-acting bronchodilators as the first intervention.

Without rapidly reversing the acute airway obstruction and correcting hypoxemia, the patient risks sudden respiratory arrest.

Address the underlying pathophysiology of the exacerbation.

Administration of systemic corticosteroids.

Asthma exacerbations are fundamentally driven by severe inflammation. Steroids take hours to reach maximal effect, so they must be given early in the treatment sequence.

Determine the efficacy of the initial tier of therapy.

Measurement of peak expiratory flow rate (PEF) and clinical reassessment.

Treatment evaluation is essential before committing to advanced adjunctive therapies. Objective measures and clinical signs dictate the next level of care.

Escalate medical therapy for a poor initial response.

Administration of intravenous magnesium sulfate.

Patients who remain in severe distress after initial treatment require adjunctive bronchodilation to prevent the need for intubation.

Manage impending ventilatory failure.

Application of non-invasive positive pressure ventilation (or intubation).

When all pharmacological options fail and the patient tires from the excessive work of breathing, mechanical support is required to maintain gas exchange.

Key Concept

The stepwise approach to severe acute asthma involves immediate rescue bronchodilation, early administration of anti-inflammatories, objective monitoring of treatment response, and subsequent escalation to adjuncts or mechanical support only if primary therapies fail.

Estimated Time:1m 30s

Question 1565Question →

A 55-year-old man is diagnosed with new-onset nonischemic cardiomyopathy and a left ventricular ejection fraction (LVEF) of $25\%$ . He presents to the outpatient clinic to establish a long-term management plan. His volume status is currently optimized with oral diuretics, and his vital signs are stable.

Arrange the following steps in the correct chronological sequence for the initiation, monitoring, and long-term evaluation of his heart failure therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence involves initiating low-dose therapy, performing early safety lab monitoring, titrating to target doses, waiting 3 to 6 months for myocardial remodeling, and then reassessing the ejection fraction to determine ICD candidacy.

The optimal management of new-onset HFrEF requires a phased approach. First, low-dose therapies are introduced in a stable patient. Because agents like ARNIs and MRAs can perturb renal function and potassium, a safety check at 1 to 2 weeks is mandatory. Following confirmation of safety, therapies must be titrated to their target doses over several weeks. Once on maximal therapy, the myocardium requires 3 to 6 months to remodel. Therefore, the ejection fraction should not be reassessed until this period has elapsed. Finally, if the LVEF remains

\leq 35\%

despite this full trial, the patient qualifies for primary prevention ICD placement.

Step-by-Step Solution

Initiate baseline low-dose guideline-directed medical therapy.

The patient starts low-dose neurohormonal blockade.

Once euvolemia is achieved, the immediate priority is introducing life-prolonging therapies.

Check a basic metabolic panel 1 to 2 weeks after initiation.

Renal function and potassium levels are verified.

RAAS inhibitors can cause acute kidney injury or hyperkalemia, making early safety monitoring crucial before any dose increases.

Titrate medications every 2 to 4 weeks to target doses.

The patient reaches the maximum tolerated doses of heart failure medications.

The mortality benefits of guideline-directed medical therapy are dose-dependent, necessitating a deliberate titration phase with concurrent monitoring.

Obtain a repeat echocardiogram 3 to 6 months later.

The current left ventricular ejection fraction is assessed.

Reverse myocardial remodeling takes several months. Assessing too early may falsely indicate a lack of recovery.

Refer for an ICD if LVEF remains severely depressed.

The patient is evaluated for sudden cardiac death primary prevention.

ICD placement is reserved for patients whose ejection fraction fails to improve to greater than

35\%

despite optimal medical management.

Key Concept

Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction requires careful initiation, early safety lab checks, sequential titration to target doses, and a 3- to 6-month period of optimal therapy before reassessing echocardiographic parameters for primary prevention device therapy.

Question 1566Question →

A 62-year-old man in the intensive care unit for severe acute pancreatitis develops a new-onset fever and leukocytosis. Blood cultures drawn from his central venous catheter and a peripheral vein both yield *Candida albicans*. He is immediately started on targeted intravenous micafungin therapy. Arrange the following steps in the most appropriate chronological sequence for the ongoing monitoring, evaluation, and therapeutic de-escalation of this patient's bloodstream infection.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with immediate source control (catheter removal), followed by daily monitoring of blood cultures to establish clearance, screening for metastatic complications via a dilated eye exam, therapeutic de-escalation to oral fluconazole, and finally terminating therapy exactly 14 days after the first negative culture.

The optimal management of candidemia requires a stepwise, evidence-based approach focused on source control, vigilant monitoring, and targeted de-escalation. Immediately upon diagnosis, the central venous catheter must be removed to eliminate the primary infectious nidus. Concurrently, daily blood cultures are initiated to pinpoint the exact day of clearance. Within the first week, a dilated ophthalmologic exam is mandatory to rule out endophthalmitis—a complication that completely alters management. Only after endophthalmitis is ruled out, clinical stability is achieved, and cultures clear, can the clinician safely step down therapy from an intravenous echinocandin to oral fluconazole. Finally, therapy is definitively stopped 14 days after the first negative blood culture.

Step-by-Step Solution

Identify the need for immediate source control.

Removal of the existing central venous catheter.

Catheter biofilms protect Candida from systemic antifungals and act as a continuous source of hematogenous seeding.

Establish the exact timeline of bloodstream clearance.

Initiation of daily serial peripheral blood cultures.

The exact date of the first negative blood culture dictates the overall required duration of therapy.

Screen for deep metastatic complications.

Consultation for a dilated ophthalmologic examination.

Endophthalmitis occurs in up to 15% of candidemia cases. It must be ruled out because it significantly extends treatment duration and may require intraocular therapy.

Evaluate for therapeutic de-escalation.

Transition from intravenous micafungin to oral fluconazole.

Once the patient is stable, cultures are negative, and deep foci (like endophthalmitis) are definitively ruled out, oral step-down minimizes hospital stay and IV complications.

Determine the therapeutic endpoint.

Discontinuation of antifungal therapy exactly 14 days post-clearance.

Uncomplicated candidemia requires exactly 14 days of systemic therapy starting from the date of the first documented negative blood culture.

Key Concept

The management of candidemia involves a strict sequence: immediate source control, serial monitoring for microbiological clearance, screening for metastatic endophthalmitis, guideline-directed therapeutic de-escalation, and a duration calculated from the first negative culture.

Alternative Method

In highly select patients where the central venous catheter cannot be removed (e.g., severe coagulopathy, lack of alternative access), echinocandins or liposomal amphotericin B are preferred due to their superior activity against Candida biofilms, though catheter salvage is rarely successful and not the standard of care.

Estimated Time:1m 30s

Question 1567Question →

A 78-year-old man is evaluated on hospital day 4 for disposition planning. He was admitted for a severe exacerbation of end-stage chronic obstructive pulmonary disease (COPD). This is his fourth hospitalization for this condition in the past 6 months. Despite maximum medical therapy with continuous noninvasive positive-pressure ventilation, intravenous methylprednisolone, and scheduled nebulized bronchodilators, he continues to experience severe dyspnea at rest, tachypnea, and marked accessory muscle use. He is visibly distressed by his air hunger. The patient, who has intact decision-making capacity, tells the physician, "I am exhausted. I do not want to be put on a breathing machine, and I just want to be kept comfortable." His wife is supportive of his wishes but is tearful, stating, "I cannot manage his severe breathing problems at home, and I am too frail to help him get out of bed."

Which of the following is the most appropriate disposition for this patient?

Discharge home with routine home hospice services

Discharge home with 24-hour home health nursing services

Transfer to a skilled nursing facility for subacute pulmonary rehabilitation

Transfer to a long-term acute care hospital for advanced respiratory support

Transfer to an inpatient hospice unit

Show answer & explanation

Answer: Transfer to an inpatient hospice unit

Answer

The most appropriate disposition is transfer to an inpatient hospice unit, as the patient requires intensive palliation for unmanaged symptoms and lacks the home caregiver support required for routine home hospice.

The patient has end-stage COPD, is experiencing severe, unmanaged symptoms (air hunger, agitation) despite maximal medical therapy, and has explicitly stated a desire for comfort-focused care. Hospice care is clearly indicated. However, routine home hospice provides intermittent nursing visits but relies on a capable primary caregiver to provide day-to-day care. Because this patient's symptoms are in crisis and his wife is too frail to manage his physical needs, routine home hospice is unsafe and inadequate. He meets the criteria for General Inpatient (GIP) hospice care, which is provided in an inpatient hospice unit. This setting offers around-the-clock skilled nursing care to rapidly titrate medications (e.g., intravenous opioids, anxiolytics) for aggressive symptom palliation.

Step-by-Step Solution

Identify the patient's goals of care based on his clinical statements.

The patient desires comfort-focused care and explicitly refuses life-prolonging measures such as intubation.

Establishing goals of care determines the appropriate treatment pathway, indicating a transition to hospice or palliative care.

Evaluate the patient's current clinical stability and symptom burden.

The patient has severe, unmanaged dyspnea and distress despite maximal medical therapy.

This determines the required intensity of palliative interventions, confirming a need for aggressive symptom management.

Assess the social and caregiver support available for a home discharge.

The wife is frail and physically unable to provide the necessary assistance or manage his severe symptom burden at home.

This rules out care settings that rely heavily on primary family caregivers, such as routine home hospice.

Select the most appropriate care setting that aligns with both medical needs and social constraints.

Inpatient hospice unit.

It provides the required high-intensity symptom management (General Inpatient level of care) that cannot be safely achieved at home.

Key Concept

Disposition to General Inpatient (GIP) hospice care is indicated for patients with a terminal prognosis who experience acute, unmanaged symptom crises that cannot be safely and effectively palliated in a routine home setting.

Question 1568Question →

An obstetrician is evaluating a primigravid individual at nine weeks of gestation for an initial prenatal encounter. The pregnancy has been uncomplicated thus far. Past medical records reveal a diagnosis of type 1 diabetes mellitus managed with a subcutaneous insulin pump. The patient's glycemic control has been excellent, with a recent hemoglobin A1c of 6.1%. Current vital signs demonstrate a blood pressure of 115/72 mmHg, a heart rate of 82/min, and a body mass index of 24 kg/m². Physical examination is unremarkable, and transvaginal ultrasonography confirms a viable single intrauterine pregnancy consistent with the current gestational age. In addition to standard prenatal care and vitamins, which of the following is the most appropriate preventive intervention to add to this management plan between twelve and sixteen weeks of gestation?

Initiation of low-dose aspirin therapy

Prophylactic low-molecular-weight heparin

Empiric labetalol therapy

Supplementation with vitamin C and vitamin E

Initiation of low-dose lisinopril therapy

Show answer & explanation

Answer: Initiation of low-dose aspirin therapy

Answer

Initiation of low-dose aspirin therapy

According to the United States Preventive Services Task Force (USPSTF) and obstetric guidelines, individuals at high risk for preeclampsia should be prescribed prophylactic low-dose aspirin (typically 81 mg/day) starting between 12 and 28 weeks of gestation (optimally before 16 weeks). High-risk clinical factors include a history of preeclampsia in a prior pregnancy, multiple gestation, chronic hypertension, pre-existing type 1 or type 2 diabetes mellitus, renal disease, and autoimmune diseases (such as systemic lupus erythematosus or antiphospholipid syndrome). Because this patient has established type 1 diabetes mellitus, she intrinsically meets the criteria for prophylactic low-dose aspirin, regardless of her current normotension or excellent glycemic control.

Step-by-Step Solution

Identify the patient's risk factors for pregnancy complications.

The patient is a primigravida with a known history of type 1 diabetes mellitus.

Recognizing maternal comorbidities is essential to stratify the risk of placental insufficiency and preeclampsia.

Consult established obstetric preventive care guidelines for this risk profile.

Pre-existing diabetes mellitus is considered a major high-risk factor for the development of preeclampsia.

The United States Preventive Services Task Force (USPSTF) recommends targeted prophylaxis for patients with high-risk conditions.

Select the appropriate prophylactic agent and timing.

Low-dose aspirin (81 mg/day) should be initiated after 12 weeks (and ideally before 16 weeks) of gestation.

Aspirin alters the balance of thromboxane and prostacyclin, promoting vasodilation and preventing the placental thrombosis and ischemia associated with preeclampsia.

Key Concept

Preeclampsia prophylaxis using low-dose aspirin in high-risk pregnancies.

Question 1569Question →

A 68-year-old biological female presents to the outpatient clinic for a routine health maintenance evaluation. She generally feels well but has a history of rheumatoid arthritis, for which she takes methotrexate and rituximab. She has a 35-pack-year smoking history and currently smokes one pack of cigarettes daily. At age 45, she underwent a total abdominal hysterectomy for symptomatic benign leiomyomas.

Her prior preventive health screenings include:
- A screening colonoscopy 9 years ago, which revealed no polyps or abnormalities.
- A screening mammogram 2 months ago, which was interpreted as normal (BI-RADS 1).
- A dual-energy x-ray absorptiometry scan 3 years ago that showed normal bone density.

Regarding her immunization history, she received the 15-valent pneumococcal conjugate vaccine (PCV15) 2 years ago, but did not return for follow-up vaccination. She received a tetanus, diphtheria, and acellular pertussis (Tdap) booster 6 years ago. She received her annual influenza vaccine 2 weeks ago at a local pharmacy. She has never received a vaccine against herpes zoster.

Which of the following preventive interventions are indicated for this patient today? (Select all that apply)

Select all that apply

Administration of 23-valent pneumococcal polysaccharide vaccine

Administration of recombinant zoster vaccine

Low-dose computed tomography of the chest

Screening colonoscopy

Vaginal cuff cytology

Show answer & explanation

Answer: Administration of 23-valent pneumococcal polysaccharide vaccine; Administration of recombinant zoster vaccine; Low-dose computed tomography of the chest

Answer

The indicated preventive interventions for this patient today are low-dose computed tomography of the chest, administration of the recombinant zoster vaccine, and administration of the 23-valent pneumococcal polysaccharide vaccine.

The correct interventions are the administration of the 23-valent pneumococcal polysaccharide vaccine (PPSV23), the administration of the recombinant zoster vaccine (RZV), and low-dose computed tomography (LDCT) of the chest. First, the patient is due for PPSV23 because it has been over a year since her dose of PCV15. Second, RZV is indicated for all adults aged 50 and older; because it is an inactivated recombinant vaccine, it is safe despite her use of immunosuppressive rituximab. Third, annual LDCT of the chest is indicated based on USPSTF guidelines for adults aged 50 to 80 years who have a 20 pack-year or greater smoking history and currently smoke or have quit within the past 15 years.

Step-by-Step Solution

Evaluate the patient's respiratory and smoking history to determine lung cancer screening eligibility.

The patient is 68 years old, has a >20 pack-year smoking history, and is a current smoker.

The USPSTF recommends annual LDCT for adults aged 50 to 80 with these specific criteria, making it indicated today.

Evaluate the patient's age and immune status to determine zoster vaccination needs.

The patient is over 50, has never received the zoster vaccine, and is on immunosuppressive therapy (rituximab).

The recombinant zoster vaccine (RZV) is a non-live vaccine indicated for all adults ≥50 years, and it is safe and recommended for immunocompromised patients.

Review the patient's pneumococcal vaccination sequence.

The patient received PCV15 two years ago but missed the follow-up dose.

ACIP guidelines mandate a dose of PPSV23 at least 1 year (or ≥8 weeks if immunocompromised) after PCV15, so she is due for PPSV23 today.

Assess the patient's gastrointestinal screening timeline.

The patient's last screening colonoscopy was normal 9 years ago.

The standard interval after a normal screening colonoscopy is 10 years; thus, it is premature to repeat it this year.

Assess the patient's gynecologic history for cervical cancer screening.

The patient has a history of a total abdominal hysterectomy for benign disease (leiomyomas).

The USPSTF recommends against screening (including vaginal cuff cytology) in women who have had a total hysterectomy for benign reasons.

Key Concept

Application of current evidence-based preventive care and screening guidelines in an older adult with multiple comorbidities, focusing on lung cancer screening, immunization sequencing, and appropriate screening intervals.

Estimated Time:1m 30s

Question 1570Question →

A 68-year-old man returns to the clinic accompanied by his wife to discuss the results of a recent lung biopsy. The pathology report unfortunately confirms stage IV non-small cell lung cancer. The physician prepares to deliver this diagnosis using a structured communication framework. Arrange the following physician actions in the most appropriate chronological order according to standard protocols for delivering bad news.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence follows the SPIKES protocol: Setting, Perception, Invitation, Knowledge, Emotion, and Strategy.

The SPIKES protocol is a well-established chronological framework for delivering bad news. It begins with 'Setting up the interview' to ensure privacy and comfort. Next is assessing the patient's 'Perception' of their condition. This is followed by obtaining the patient's 'Invitation' regarding how much information they want. The physician then provides the 'Knowledge' clearly and directly. Immediately after, the physician must address the patient's 'Emotions' with empathy. Finally, the encounter concludes with a 'Strategy and Summary' to outline the next steps.

Step-by-Step Solution

Identify the clinical scenario

The physician needs to deliver a poor prognosis (stage IV lung cancer) to the patient.

Recognizing the need to deliver bad news dictates the use of a structured communication protocol.

Recall the standard protocol

The SPIKES protocol is the standard framework used in medical practice for delivering bad news.

Applying the correct framework ensures all necessary steps are taken to support the patient.

Map the actions to the protocol steps

The actions correspond to Setting, Perception, Invitation, Knowledge, Emotion, and Strategy.

Each action must be placed in its specific chronological position to be effective.

Arrange the actions sequentially

The sequence is established from preparation to information gathering, delivery, support, and finally planning.

This sequential order minimizes psychological trauma and maximizes patient comprehension.

Key Concept

The SPIKES protocol provides a structured, six-step approach for delivering bad news in a compassionate and effective manner.

Question 1571Question →

A multidisciplinary discharge planning committee is reviewing the profiles of four hospitalized individuals who are preparing for transition out of the acute care ward. Match each patient profile with the most appropriate post-acute care setting that best aligns with clinical guidelines, medical complexity, and rehabilitation tolerance.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct mapping pairs the ventilator weaning patient with LTACH, the patient tolerating 3 hours of therapy with IRF, the frail post-arthroplasty patient with SNF, and the stable IV antibiotic patient with Home Health.

Each setting has strict criteria: LTACHs manage high medical acuity requiring prolonged hospitalization, IRFs require a minimum of 3 hours of daily therapy tolerance, SNFs accommodate lower therapy tolerance with skilled nursing needs, and Home Health manages specific medical interventions in stable, independent patients living in the community.

Step-by-Step Solution

Assess the patient requiring prolonged ventilator weaning and extensive wound care.

Matches with Long-Term Acute Care Hospital (LTACH).

These patients have high medical acuity requiring extended hospitalization (typically >25 days) but do not require acute ICU interventions.

Evaluate the post-stroke patient's rehabilitation capacity.

Matches with Inpatient Rehabilitation Facility (IRF).

The ability to tolerate 3 hours of daily multidisciplinary therapy is the core requirement for IRF admission.

Analyze the frail post-arthroplasty patient's endurance.

Matches with Skilled Nursing Facility (SNF).

Needing daily physical therapy but only tolerating 45 minutes disqualifies the patient from an IRF, making a SNF the appropriate step-down level of care.

Determine the needs of the patient on IV daptomycin.

Matches with Home Health Agency (HHA) services.

Being medically stable and independent means inpatient post-acute care is unnecessary; home health can safely manage vascular access and intermittent infusions.

Key Concept

Clinical acuity, rehabilitation tolerance, and specific skilled nursing needs dictate the appropriate post-acute care setting according to Medicare-defined admission criteria.

Question 1572Question →

A 74-year-old woman is hospitalized for acute decompensated heart failure and a concurrent chronic obstructive pulmonary disease (COPD) exacerbation. She is now clinically stable, euvolemic on oral diuretics, and transitioned to room air. The medical team is initiating the discharge planning process. To ensure a safe transition of care and minimize the risk of readmission, arrange the following discharge planning steps in the most appropriate chronological sequence.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Risk evaluation, multidisciplinary setting determination, medication reconciliation, teach-back education, and finally, transmission of the discharge summary.

The correct sequence follows established transitions of care frameworks (e.g., IDEAL, Project BOOST). Early identification of readmission risk dictates the intensity of discharge planning. The multidisciplinary team then establishes the appropriate care setting based on functional needs. Once the destination is set, the physician finalizes the medication orders through reconciliation. Only after the medical plan is finalized can the patient be properly educated using the teach-back method. Finally, transmitting the discharge summary to the receiving provider ensures continuity of care as the patient transitions out of the hospital.

Step-by-Step Solution

Identify the need for early risk stratification.

Readmission risk is calculated first.

Determines the trajectory and intensity of the entire discharge planning process.

Determine the appropriate level of post-acute care.

Multidisciplinary assessment selects the destination.

The care setting dictates the logistical requirements for the remainder of the discharge process.

Finalize the medical treatment plan.

Medication reconciliation is performed.

An accurate medication list must be generated before the patient can be educated on it.

Educate the patient and caregivers.

Teach-back method is utilized.

Ensures comprehension of the finalized medications and warning signs prior to leaving the hospital.

Execute the provider handoff.

Discharge summary is transmitted.

Closes the loop by informing the next provider of care about the completed hospital course and post-discharge plan.

Key Concept

Optimal transitions of care require a structured, chronological approach beginning with early risk assessment, followed by multidisciplinary planning, medication reconciliation, patient education, and concluding with definitive provider handoff.

Question 1573Question →

A 68-year-old man comes to the clinic for a routine health maintenance examination. He has a history of essential hypertension, hyperlipidemia, and osteoarthritis. His current medications include lisinopril, atorvastatin, and occasional acetaminophen. He smoked one pack of cigarettes daily for 30 years but quit at age 55. His vital signs are within normal limits. The physician recommends a one-time abdominal duplex ultrasound to screen for an abdominal aortic aneurysm. The patient immediately shakes his head, crosses his arms, and says, "I am absolutely not doing that. My older brother had a scan for his belly a few years ago. They found a tiny shadow that led to three painful biopsies, a major surgery, and he almost died from a hospital infection. It turned out he didn't even have cancer. I feel perfectly fine, and I am not opening Pandora's box when I have no symptoms." Which of the following is the most appropriate initial response by the physician?

Unlike your brother's test, this ultrasound is a standard preventive screening recommended for all men over the age of 65, regardless of symptoms.

If you are concerned about unnecessary biopsies, we could perform a screening computed tomography scan of the abdomen instead, which provides better detail.

It sounds like your brother went through a terrifying ordeal. Can you tell me more about your specific concerns regarding this ultrasound?

Because you are legally competent, you have the right to decline; however, I must document that this refusal goes against medical advice.

I understand your hesitation. We can defer the ultrasound for now and reconsider it immediately if you develop any abdominal or back pain.

Show answer & explanation

Answer: It sounds like your brother went through a terrifying ordeal. Can you tell me more about your specific concerns regarding this ultrasound?

Answer

The most appropriate response is to empathetically acknowledge the brother's traumatic experience and ask an open-ended question to explore the patient's specific fears regarding the ultrasound.

The correct response exemplifies fundamental patient-centered communication. When a patient demonstrates strong emotional resistance or holds health beliefs based on negative personal or family experiences, the physician must first establish an empathetic alliance. Validating the emotional weight of the brother's experience and using an open-ended question to explore the patient's specific fears builds trust. Only after the patient feels heard and the exact nature of their hesitation is understood should the physician provide targeted medical education and clarify misconceptions.

Step-by-Step Solution

Identify the primary clinical challenge presented in the vignette.

The patient is refusing a highly recommended screening test (abdominal aortic aneurysm screening) due to strong emotional resistance stemming from a family member's negative medical experience.

Understanding the root cause of the refusal (fear of a cascade of unnecessary interventions) is required to select the correct communication strategy.

Evaluate the physician's communication priorities.

Before correcting misconceptions or pushing for the test, the physician must establish a therapeutic alliance by addressing the emotional barrier.

Patients exhibiting strong negative emotions or defensiveness are unlikely to process factual medical information or guidelines until they feel heard and understood.

Select the response that demonstrates patient-centered communication.

The correct statement uses empathetic validation ("It sounds like your brother went through a terrifying ordeal") followed by open-ended exploration ("Can you tell me more...").

This approach prevents premature closure, avoids adversarial interactions, and allows the physician to gather the specific context needed to tailor subsequent health education.

Key Concept

When patients refuse medical recommendations due to fear or past negative experiences, the most appropriate initial physician response is empathetic validation and open-ended exploration of their concerns.

Question 1574Question →

A 60-year-old man presents to the outpatient clinic for a routine follow-up visit. His medical history includes type 2 diabetes mellitus, heart failure with reduced ejection fraction (ejection fraction 35%), and paroxysmal atrial fibrillation. His prescribed medications include metformin, lisinopril, metoprolol succinate, and warfarin. During the encounter, the patient states, "I stopped taking my warfarin a month ago. A friend at my gym told me it causes brain bleeds. Besides, I started eating a large spinach salad every day to naturally keep my blood healthy." He also casually mentions that he canceled his scheduled screening colonoscopy because his bowel movements are completely normal and he experiences no abdominal pain.

Which of the following is the most appropriate next step in the management of this patient?

Explore the patient's specific concerns regarding warfarin and assess his understanding of his stroke risk.

Request a psychiatric consultation to evaluate the patient's legal competence to refuse standard-of-care therapy.

Agree to defer colon cancer screening, as it is not currently indicated for asymptomatic patients with normal bowel habits.

Suggest combining over-the-counter naproxen with daily high-dose aspirin as an alternative method for stroke prophylaxis.

Prescribe verapamil in place of metoprolol to ensure strict rate control while the patient is off anticoagulation.

Show answer & explanation

Answer: Explore the patient's specific concerns regarding warfarin and assess his understanding of his stroke risk.

Answer

Explore the patient's specific concerns regarding warfarin and assess his understanding of his stroke risk.

The correct action is to explore the patient's specific concerns regarding the anticoagulant and assess his understanding of his stroke risk. When a patient is non-adherent due to misinformation (such as advice from a gym friend) or fear of side effects, the most appropriate initial step in patient counseling is to use open-ended questions. This approach builds the therapeutic alliance, validates the patient's autonomy, and uncovers the precise nature of their misunderstanding, allowing the physician to provide targeted, effective health education. Dismissing the concerns, immediately altering the treatment plan, or questioning the patient's competence bypasses this critical communication step.

Step-by-Step Solution

Identify the core clinical issue presented in the vignette.

A patient with multiple severe comorbidities is non-adherent to high-risk medication due to fear and misinformation, and is also avoiding age-appropriate preventive screening.

Understanding the patient's actions and the motivations behind them dictates the physician's counseling strategy.

Determine the priority in the physician-patient interaction.

The physician must first understand the patient's health literacy, fears, and specific misconceptions before attempting to alter the treatment plan or correct his behavior.

Premature reassurance, immediate correction, or abrupt medication changes bypass patient autonomy and often result in further non-adherence.

Select the most appropriate initial communication strategy.

Using open-ended questions to explore the patient's specific beliefs about warfarin establishes a therapeutic alliance and guides targeted health education.

This aligns with best practices in patient counseling and motivational interviewing.

Key Concept

Patient Counseling and Health Education

Question 1575Question →

A 62-year-old woman is preparing to leave the inpatient ward following a 6-day admission for a complicated myocardial infarction. She will be returning to her independent living apartment. To optimize patient safety during this care transition and prevent readmission, arrange the following discharge planning interventions in the most appropriate chronological sequence, from initial preparation to final outpatient handoff.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for a safe discharge transition begins with assessing patient needs, followed by reconciling the medical plan, coordinating logistical support, educating the patient, and finally completing the provider handoff.

A safe and effective transition of care requires a logical progression. It must begin with assessing the patient's baseline and social determinants. Only then can the physician safely finalize the medical plan through comprehensive medication reconciliation. With the medical plan established, logistical coordination such as home health and equipment can be accurately arranged. Once all elements of the discharge are finalized, comprehensive patient education via the teach-back method is performed. Finally, the completed documentation and pending items are handed off to the outpatient provider to ensure continuity.

Step-by-Step Solution

Identify the foundational first step in transition planning.

Assessing health literacy and functional baseline.

Any safe discharge plan must be built upon an accurate understanding of the patient's cognitive capabilities and home environment to avoid creating a medically ideal but practically impossible plan.

Determine the next priority in formulating the medical plan.

Performing medication reconciliation.

Adverse drug events are a leading cause of post-discharge complications. Finalizing the medication list is required before organizing specific home services or providing patient education.

Identify the step that implements the logistical aspects of the medical plan.

Coordinating durable medical equipment and home health.

Logistical resources must be arranged to support the established medical requirements and functional deficits identified in earlier steps.

Select the optimal timing for patient education.

Educating the patient using the teach-back method.

Effective education requires the complete, finalized plan to be firmly established so the patient receives a single, cohesive set of instructions.

Identify the final communication step of the transition.

Transmitting the discharge summary to the primary care physician.

Provider-to-provider handoff occurs as the patient leaves the facility, acting as the definitive record of the completed transition plan.

Key Concept

Standardized transitions of care protocols emphasize a sequential approach starting with patient assessment, followed by medication reconciliation, coordination of resources, patient education, and a finalized provider handoff to minimize adverse events and readmissions.

Question 1576Question →

For the following adult patients receiving end-of-life care, identify the most appropriate targeted pharmacologic therapy to manage their acute distressing symptoms.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The clinical scenarios are correctly paired with their specific symptom-directed therapies: the patient with dyspnea requires a systemic opioid, the patient with terminal secretions requires a muscarinic antagonist, the patient with opioid neurotoxicity and acute kidney injury requires opioid rotation, and the patient with agitated terminal delirium requires an antipsychotic.

Each clinical scenario presents a classic end-of-life symptom requiring a targeted pharmacologic intervention. Dyspnea is best managed with opioids to reduce the perception of breathlessness. Terminal secretions respond to anticholinergics that decrease fluid production. Opioid neurotoxicity in renal failure necessitates rotation to an opioid metabolized safely, like fentanyl. Severe agitated delirium is treated with antipsychotics when non-pharmacological interventions fail.

Step-by-Step Solution

Evaluate the 82-year-old patient with refractory dyspnea.

Recognize that opioids are the gold standard for treating dyspnea at the end of life.

Opioids decrease the central respiratory drive and alleviate the sensation of air hunger.

Assess the 69-year-old patient with loud, gurgling respiratory noises.

Identify this as terminal secretions ('death rattle').

These secretions require anticholinergic drying agents, as suctioning is often ineffective and distressing.

Analyze the 58-year-old patient with myoclonus, allodynia, and acute kidney injury on hydromorphone.

Diagnose opioid-induced neurotoxicity due to metabolite accumulation.

Renal failure prevents the clearance of neurotoxic metabolites; the patient must be rotated to a renally safe opioid like fentanyl.

Evaluate the 75-year-old patient with hyperactive, aggressive behavior.

Diagnose terminal agitated delirium.

When non-pharmacologic measures fail, antipsychotics are required to manage severe agitation and ensure safety.

Key Concept

Pharmacologic management of terminal symptoms (dyspnea, secretions, delirium, opioid neurotoxicity) in end-of-life care

Question 1577Question →

A 61-year-old man is evaluated in the intensive care unit. He was admitted 14 days ago for severe necrotizing pancreatitis. On hospital day 8, he developed a deep venous thrombosis and was started on an unfractionated heparin infusion. Three days later, his platelet count dropped from $240,000/\text{mm}^3$ to $85,000/\text{mm}^3$ . A serotonin release assay was positive, confirming heparin-induced thrombocytopenia (HIT). All heparin products were discontinued, and a continuous intravenous infusion of argatroban was initiated.

The patient's clinical condition has since stabilized. Three days ago, oral warfarin was initiated for long-term anticoagulation. Today, his platelet count has recovered to $175,000/\text{mm}^3$ .

Laboratory Test	Result
Prothrombin time (PT)	28 seconds
International normalized ratio (INR)	2.7
Activated partial thromboplastin time (aPTT)	68 seconds

The target INR for this patient's long-term management is 2.0 to 3.0.

Which of the following are appropriate steps in the ongoing monitoring and therapeutic evaluation for this patient? (Select all that apply)

Select all that apply

Continue the argatroban infusion alongside warfarin until the combined INR exceeds 4.0

Discontinue the argatroban infusion today and continue warfarin monotherapy

Discontinue warfarin and initiate therapeutic-dose enoxaparin as a bridge to outpatient therapy

Measure a chromogenic factor Xa level to assess the isolated anticoagulant effect of warfarin

Suspend the argatroban infusion for 4 hours and repeat the INR to confirm it remains between 2.0 and 3.0

Show answer & explanation

Answer: Continue the argatroban infusion alongside warfarin until the combined INR exceeds 4.0; Measure a chromogenic factor Xa level to assess the isolated anticoagulant effect of warfarin

Answer

The correct steps are to continue the argatroban infusion alongside warfarin until the combined INR exceeds 4.0, AND to measure a chromogenic factor Xa level to assess the isolated anticoagulant effect of warfarin.

The correct answers address the pharmacokinetic artifact caused by direct thrombin inhibitors. Because argatroban falsely elevates the INR, patients transitioning to warfarin must remain on co-therapy until the combined INR is at least >4.0. Only then should argatroban be paused for 4 to 6 hours to check a true, isolated warfarin INR. Alternatively, clinicians can circumvent the INR artifact entirely by ordering a chromogenic factor Xa level. This assay measures the depletion of Factor X (dependent on vitamin K antagonism) and does not rely on thrombin generation, making it highly accurate for monitoring warfarin in the presence of argatroban.

Step-by-Step Solution

Identify the patient's current clinical state

The patient is in the subacute phase of heparin-induced thrombocytopenia (HIT) with platelet recovery, currently transitioning from argatroban to warfarin.

Establishing the phase of HIT is essential, as transition to oral vitamin K antagonists (VKA) can only safely occur once platelets recover above 150,000/mm^3.

Interpret the laboratory findings in the context of the current medications

The INR of 2.7 is artificially elevated. Argatroban is a direct thrombin inhibitor (DTI) that falsely prolongs the prothrombin time (PT) and INR.

Failing to account for the DTI-induced INR artifact will lead to premature discontinuation of parenteral anticoagulation and severe thrombotic complications.

Determine the appropriate monitoring protocol for argatroban-to-warfarin transition

Guidelines dictate continuing both drugs until the combined INR is > 4.0, or using an alternative monitoring assay like chromogenic factor Xa.

When combined INR > 4.0, argatroban is stopped for 4-6 hours, and the INR is rechecked to ensure it remains therapeutic (2.0-3.0) on warfarin alone. Chromogenic factor Xa assays bypass the thrombin pathway and isolate warfarin's effect.

Key Concept

Monitoring the transition from argatroban to warfarin in heparin-induced thrombocytopenia requires accounting for the artificial INR elevation caused by direct thrombin inhibitors.

Question 1578Question →

During morning rounds on the medical ward, the care team discusses the transition plan for a 68-year-old woman. She has been hospitalized for two weeks after presenting with severe sepsis from a perforated diverticulum. Her initial course required an emergent exploratory laparotomy, colostomy creation, and a 10-day intensive care unit stay complicated by acute respiratory distress syndrome that required mechanical ventilation.

She was extubated three days ago and transferred to the floor. Her vital signs are temperature 37.1°C (98.8°F), blood pressure 124/78 mmHg, pulse 80/min, and respirations 16/min. She is breathing comfortably on room air. The surgical incision is healing appropriately, and the colostomy is functioning well.

A physical therapy assessment reveals profound generalized muscle weakness consistent with critical illness polyneuropathy. The patient requires maximum physical assistance from two staff members to transfer from the bed to a chair and cannot bear weight independently. Despite being highly motivated to recover, she becomes visibly exhausted after 30 to 45 minutes of combined physical and occupational therapy. Prior to admission, she lived at home with her husband, who suffers from advanced heart failure and relies on a wheelchair.

What is the most appropriate disposition for this patient?

Transfer to a skilled nursing facility

Transfer to an inpatient rehabilitation facility

Discharge home with visiting home health services

Transfer to a long-term acute care hospital

Transfer to an assisted living facility

Show answer & explanation

Answer: Transfer to a skilled nursing facility

Answer

Transfer to a skilled nursing facility

The correct disposition is a skilled nursing facility (SNF). This patient is medically stable following a severe illness but suffers from critical illness polyneuropathy. She requires daily skilled nursing and physical therapy to regain her functional independence. An SNF provides subacute rehabilitation for patients who need daily therapy but lack the stamina to endure the 3 hours of intensive daily therapy mandated by inpatient rehabilitation facilities (IRFs). Because she maxes out at 45 minutes of therapy and requires maximum assistance for transfers that her husband cannot provide, an SNF is the safest and most appropriate environment for her ongoing recovery.

Step-by-Step Solution

Evaluate the patient's current medical stability and need for ongoing acute medical care.

The patient is extubated, afebrile, and hemodynamically stable with healing wounds.

Determines whether the patient requires a long-term acute care hospital (LTACH) versus a post-acute rehabilitation setting.

Assess the patient's functional status and rehabilitation capacity.

The patient has severe weakness and can only tolerate 30 to 45 minutes of therapy before exhaustion.

Differentiates between the need for an inpatient rehabilitation facility (which requires tolerating 3 hours/day) and a skilled nursing facility.

Analyze the patient's social support and home environment.

The patient lives with a husband who is wheelchair-bound and unable to assist with transfers.

Determines if discharge home with home health services is safe and feasible.

Key Concept

Patients who require inpatient rehabilitation but cannot tolerate the 3 hours of daily therapy required for an inpatient rehabilitation facility (IRF) should be transferred to a skilled nursing facility (SNF).

Question 1579Question →

A $54$ -year-old male is evaluated on hospital day $4$ for altered mental status. He was originally admitted for severe alcohol withdrawal complicated by generalized tonic-clonic seizures. The patient was successfully stabilized with intravenous lorazepam followed by a loading dose of phenytoin, and he is currently receiving an oral phenytoin maintenance regimen. His medical history is significant for severe alcohol use disorder and decompensated cirrhosis. Today, the nursing staff notes that the patient is increasingly confused, lethargic, and dysarthric. When attempting to walk to the bathroom, he exhibited a wide-based, unsteady gait. Vital signs are within normal limits. Neurologic examination reveals prominent bilateral horizontal nystagmus. Asterixis is absent. Laboratory studies show the following:

Laboratory Test	Result	Reference Range
Albumin	$1.9\text{ g/dL}$	$3.5-5.0\text{ g/dL}$
Total bilirubin	$3.5\text{ mg/dL}$	$0.1-1.2\text{ mg/dL}$
Ammonia	$35\text{ \mu mol/L}$	$15-45\text{ \mu mol/L}$
Total serum phenytoin	$11\text{ mg/L}$	$10-20\text{ mg/L}$

Which of the following is the most appropriate next step in the management of this patient?

Measure serum free phenytoin concentration

Increase the oral phenytoin maintenance dose

Obtain a noncontrast computed tomography scan of the head

Administer oral lactulose

Initiate concomitant valproic acid therapy

Show answer & explanation

Answer: Measure serum free phenytoin concentration

Answer

The most appropriate next step is to measure the serum free phenytoin concentration to accurately assess for drug toxicity in the setting of severe hypoalbuminemia.

This patient presents with classic manifestations of phenytoin toxicity, including altered mental status, horizontal nystagmus, dysarthria, and ataxia. While his total serum phenytoin level of

11\text{ mg/L}

appears to be within the normal therapeutic range (

10-20\text{ mg/L}

), this value is deceiving due to his underlying severe cirrhosis and resulting hypoalbuminemia. Phenytoin is approximately

90\%

bound to plasma proteins, primarily albumin. In disease states characterized by low albumin (e.g., decompensated cirrhosis, nephrotic syndrome, severe malnutrition), the fraction of unbound, active phenytoin increases significantly. The standard laboratory test for phenytoin measures the total concentration (bound plus unbound). Therefore, a seemingly normal total phenytoin level in a patient with an albumin of

1.9\text{ g/dL}

represents a massive increase in the free, pharmacologically active drug crossing the blood-brain barrier. The most appropriate next step in treatment evaluation is to order a serum free phenytoin concentration, which provides an accurate assessment of the drug's true systemic exposure and confirms the diagnosis of toxicity.

Step-by-Step Solution

Analyze the patient's clinical presentation.

The patient exhibits confusion, dysarthria, ataxia, and horizontal nystagmus.

These findings are classic, hallmark signs of phenytoin toxicity.

Evaluate the laboratory results in the context of the medication regimen.

The total serum phenytoin level is

11\text{ mg/L}

, which falls within the standard therapeutic range of

10-20\text{ mg/L}

. However, the patient has profound hypoalbuminemia (

1.9\text{ g/dL}

Phenytoin is highly protein-bound in the serum. Evaluating the albumin level is crucial when interpreting total phenytoin levels.

Synthesize the pharmacokinetic principles to determine the next management step.

Because albumin is low, there are fewer binding sites for phenytoin. The absolute amount of unbound (free) phenytoin increases, penetrating the central nervous system and causing toxicity, even though the 'total' level appears normal. The next step is to measure the free phenytoin level.

Treatment evaluation and dose adjustments for highly protein-bound drugs in malnourished or cirrhotic patients must rely on the free fraction rather than the total fraction.

Key Concept

In patients with significant hypoalbuminemia, standard total serum phenytoin levels underestimate the amount of free (active) drug. Clinicians must measure free phenytoin levels or calculate an adjusted level to properly evaluate therapy and prevent severe toxicity.

Alternative Method

Instead of ordering a serum free phenytoin level, clinicians can quickly calculate the patient's estimated adjusted total phenytoin level using the Winter-Tozer equation: Adjusted Phenytoin = Measured Total Phenytoin / ((0.2 × Albumin) + 0.1). For this patient, the adjusted level would be 11 / ((0.2 × 1.9) + 0.1) = 11 / 0.48 = 22.9 mg/L. This calculated value exceeds the therapeutic upper limit of 20 mg/L, confirming clinical toxicity.

Estimated Time:2m 0s

Question 1580Question →

A 31-year-old man with a history of treatment-resistant schizophrenia is evaluated during a routine follow-up visit. He was started on clozapine $6$ weeks ago after failing trials of risperidone, aripiprazole, and haloperidol. He is currently maintained on a stable dose of $300 \text{ mg/day}$ . The patient is of Northern European descent. He reports feeling well, with a significant reduction in his auditory hallucinations, and has no fever, chills, sore throat, or malaise. His temperature is $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), blood pressure is $122/78 \text{ mmHg}$ , and pulse is $82/\text{min}$ . Routine laboratory testing reveals a total leukocyte count of $4,200/\mu\text{L}$ and an absolute neutrophil count of $1,350/\mu\text{L}$ . Prior to initiating clozapine, his absolute neutrophil count was $3,600/\mu\text{L}$ . Which of the following is the most appropriate next step in the management of this patient?

Continue clozapine and monitor the absolute neutrophil count three times weekly

Discontinue clozapine indefinitely and initiate a trial of olanzapine

Order a bone marrow aspiration and biopsy

Discontinue clozapine and initiate carbamazepine

Continue clozapine and prescribe empiric ciprofloxacin prophylaxis

Show answer & explanation

Answer: Continue clozapine and monitor the absolute neutrophil count three times weekly

Answer

Continue clozapine and monitor the absolute neutrophil count three times weekly.

The correct management for this patient is to continue clozapine and monitor the absolute neutrophil count (ANC) three times weekly. According to the Clozapine Risk Evaluation and Mitigation Strategy (REMS) guidelines for patients in the general population (without benign ethnic neutropenia), an ANC between

1,000/\mu\text{L}

and

1,499/\mu\text{L}

constitutes mild neutropenia. In this scenario, clozapine should not be discontinued; instead, the clinician must increase the frequency of ANC monitoring to three times weekly until the ANC reaches or exceeds

1,500/\mu\text{L}

. Treatment interruption is only required if the ANC falls below

1,000/\mu\text{L}

(moderate neutropenia), and permanent discontinuation is mandated if the ANC drops below

500/\mu\text{L}

(severe neutropenia/agranulocytosis).

Step-by-Step Solution

Evaluate the patient's absolute neutrophil count (ANC) against the standard reference thresholds.

The patient's ANC is

1,350/\mu\text{L}

Accurate interpretation of the ANC is required to apply the Clozapine Risk Evaluation and Mitigation Strategy (REMS) guidelines.

Determine the neutropenia severity category for a patient without Benign Ethnic Neutropenia (BEN).

An ANC between

1,000/\mu\text{L}

and

1,499/\mu\text{L}

is classified as mild neutropenia.

Management protocols strictly depend on the precise severity classification of neutropenia.

Apply the guideline-directed management for mild neutropenia.

The correct action is to continue clozapine therapy and increase ANC monitoring frequency to three times weekly.

Mild neutropenia does not warrant therapy interruption, but closer surveillance is mandated until the ANC returns to

\ge 1,500/\mu\text{L}

Key Concept

Clozapine REMS guidelines mandate that patients with mild neutropenia (ANC

1,000 - 1,499/\mu\text{L}

) should continue clozapine therapy but undergo increased ANC monitoring (three times weekly) until the count normalizes.

PreviousPage 79 / 104Next

Patient Management

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Alternative Method

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Alternative Method

Answer